Menu
Back to Journals » Journal of Pain Research » Volume 5
Crucial involvement of actin filaments in celecoxib and morphine analgesia in a model of inflammatory pain
Authors Paiva-Lima, Rezende, Leite, Duarte, Bakhle, Francischi J
Received 9 August 2012
Accepted for publication 3 October 2012
Published 9 November 2012 Volume 2012:5 Pages 535—545
DOI https://doi.org/10.2147/JPR.S36870
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Patrícia Paiva-Lima,1 Rafael M Rezende,1 Rômulo Leite,2 Igor DG Duarte,1 YS Bakhle,3 Janetti N Francischi1
1Department of Pharmacology, Laboratory of Inflammation and Pain, Biological Sciences Institute, Federal University of Minas Gerais, Brazil; 2Department of Pharmacology, Faculty of Pharmacy, Federal University of Ouro Preto, Minas Gerais, Brazil; 3Leukocyte Biology, National Heart and Lung Institute, Faculty of Medicine, Imperial College, London, UK
Background: Celecoxib exerted analgesic effects (hypoalgesia) reversed by opioid receptor antagonists in a model of inflammatory pain. To analyze this celecoxib-induced hypoalgesia further, we assessed the effects of several disruptors of cytoskeletal components in our model of inflammation.
Methods: Hyperalgesia to mechanical stimuli was induced in rat hind paws by intraplantar injection of carrageenan and measured using the Randall-Selitto method over the next 8 hours. The effects of systemic pretreatment with celecoxib and a range of cytoskeletal disruptors (colchicine, nocodazole, cytochalasin B, latrunculin B, acrylamide, each given by intraplantar injection) on carrageenan-induced hyperalgesia were similarly investigated. Morphine and other selective cyclo-oxygenase 1 (SC-560), cyclo-oxygenase 2 (SC-236), and nonselective cyclo-oxygenase (indomethacin) inhibitors were also tested under similar conditions.
Results: None of the cytoskeletal disruptors affected the peak intensity of carrageenan-induced hyperalgesia, and its duration was increased only by nocodazole and colchicine. Pretreatment with celecoxib 30 minutes before carrageenan reversed the hyperalgesia and raised the nociceptive threshold (hypoalgesia). All analgesic effects of celecoxib were blocked by nocodazole, colchicine, cytochalasin B, and latrunculin B. Pretreatment with morphine also induced hypoalgesia in carrageenan-inflamed paws, an effect reversed by colchicine and cytochalasin B. However, the analgesic effects of indomethacin were not reversed by disruption of actin filaments with cytochalasin B or latrunculin B.
Conclusion: These data strengthen the correlation between cytoskeletal structures and the processes of pain and analgesia.
Keywords: hypoalgesia, celecoxib, morphine, cytoskeleton, actin, cyclo-oxygenases
© 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.